XLVState Street Health Care Select Sector SPDR ETF
Seeks to provide investment results that correspond to the price and yield performance of publicly traded equity securities in the Index.
By State Street Investment Management · Launched 1998
Annual Cost
0.08%
#408 of 5,562 · low cost
Fund Size
$38.2B
#90 of 5,562 · large
Return (1Y)Goal
+13.9%
Track Record
27 years
#56 of 5,562 · established
Performance
Total-return NAV · USDGrowth of $10,000
$11,470+14.7%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Large
Strategy
Index tracking
Sector
Health careIndex tracked
Health Care Select Sector Index
What it actually holds
By weightConcentration
Top 10 holdings = 58.4% of fundmoderately concentrated
Eli Lilly & Co
15.2%
Johnson & Johnson
8.9%
AbbVie Inc
7.2%
UnitedHealth Group Inc
5.3%
Merck & Co Inc
4.7%
Abbott Laboratories
3.9%
Thermo Fisher Scientific Inc
3.9%
Intuitive Surgical Inc
3.6%
Amgen Inc
3.1%
Gilead Sciences Inc
2.7%
Asset allocation
Stocks
99.9%
Cash
0.1%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
15.0%Moderate
Year-on-year price swings
Max drawdown
-28.4%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.24Below average
Sortino (3Y)
0.33Moderate downside risk
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks to provide investment results that correspond to the price and yield performance of publicly traded equity securities in the Index.
- Strategy
- Invests primarily in publicly traded equity securities of companies in the Health Care Select Sector. Aims to track the performance of the Health Care Select Sector Index.
- Inception date
- December 16, 1998
- Fund family
- State Street Investment Management
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed XLV. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19